跳至主要内容
临床试验/NCT05861791
NCT05861791已完成不适用

Comparison of Patient-controlled Analgesia With Background Opioid Versus Non-opioid Infusion for Postoperative Pain in Patients Undergoing Total Knee Arthroplasty: a Randomized, Non-inferiority Study

Chung-Ang University Gwangmyeong Hospital1 个研究点 分布在 1 个国家目标入组 98 人开始时间: 2023年2月7日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
98
试验地点
1
主要终点
postoperative pain score

研究概览

简要总结

Patients who undergoing total knee arthroplasty under spinal analgesia will be recruited and randomly assigned to the following two groups according to the regimen of PCA: (A) opioid group who receive only fentanyl citrate 1200mcg for continuous infusion drug, (B) non-opioid group who receive ketorolac tromethamine 150mg with nefopam hydrochloride 100mg for continuous infusion drug. All the patients will receive additional fentanyl citrate as bolus injection drug if they need more analgesics postoperatively.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
60 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA physical status I-II
  • undergoing elective total knee arthroplasty under spinal anesthesia

排除标准

  • history of stomack ulceration
  • increased ICP
  • bronchial asthma
  • allergy on aspirin, NSAIDs, Nefopam
  • drug user of antiplatelet or anticoagulant

研究组 & 干预措施

opioid group

Experimental

IV-PCA consisted of fentanyl

干预措施: Fentanyl (Drug)

non-opioid group

Active Comparator

IV-PCA consisted of ketorolac and nefopam

干预措施: ketorolac tromethamine with nefopam hydrochloride (Drug)

结局指标

主要结局

postoperative pain score

时间窗: 24 hours after the surgery

evaluated by visual analogue scale

次要结局

未报告次要终点

研究者

发起方
Chung-Ang University Gwangmyeong Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Se-Hee Min

Assistant professor

Chung-Ang University Gwangmyeong Hospital

研究点 (1)

Loading locations...

相似试验